These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4397459)

  • 1. The effect of angiotensin II on the release of catecholamines in the sheep.
    O'Gorman LP; Evans FR; Osborn EC; Mahler RF
    J Pharm Pharmacol; 1971 Jul; 23(7):545-7. PubMed ID: 4397459
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of reserpine and guanethidine treatment on urinary catecholamines and metabolites in chronic hypertensive dogs.
    Moerman EJ; de Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:310-. PubMed ID: 5052484
    [No Abstract]   [Full Text] [Related]  

  • 3. An asymptomatic catecholamine-secreting pheochromocytoma.
    Taubman I; Pearson OH; Anton AH
    Am J Med; 1974 Dec; 57(6):953-6. PubMed ID: 4432874
    [No Abstract]   [Full Text] [Related]  

  • 4. Excretion of catecholamine in urine by infants and children with cyanotic congenital heart disease.
    Folger GM; Hollowell JG
    Pediatr Res; 1972 Mar; 6(3):151-7. PubMed ID: 5046972
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of large variations in diet on free catecholamines and their metabolites in urine.
    Cardon PV; Guggenheim FG
    J Psychiatr Res; 1970 Jul; 7(4):263-73. PubMed ID: 5477766
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenal function and alcoholism. II. Catecholamines.
    Ogata M; Mendelson JH; Mello NK; Majchrowicz E
    Psychosom Med; 1971; 33(2):159-80. PubMed ID: 5549660
    [No Abstract]   [Full Text] [Related]  

  • 7. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
    Käser H; Türler K; Burri PH
    Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary catecholamines and metabolites in renal hypertensive dogs.
    Moerman EJ; De Schaepdryver AF
    J Med; 1972; 3(2):97-102. PubMed ID: 4507073
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenal medullary contribution to the progressive pressor response to angiotensin in the rabbit.
    Dickinson CJ; De Swiet M; De Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):304-8. PubMed ID: 4304368
    [No Abstract]   [Full Text] [Related]  

  • 10. Dextroamphetamine, catecholamines, and behavior. The effect of dextroamphetamine in retarded children.
    Anton AH; Greer M
    Arch Neurol; 1969 Sep; 21(3):248-52. PubMed ID: 5802455
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
    Sakuma N; Nagasaka N
    ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine measurements in pheochromocytoma and neuroblastoma.
    Spiegel HE
    Ann Clin Lab Sci; 1974; 4(3):174-7. PubMed ID: 4363482
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. 2. Clinical studies on urinary metanephrine and normetanephrine in patients with pheochromyocytoma and a patient with neuroblastoma].
    Shimbo S
    Naika Hokan; 1968 Sep; 15(9):299-310. PubMed ID: 5752086
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ
    Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sleep deprivation on the excretion of metanephrine and normetanephrine.
    Kuhn E; Rysánek K; Kujalová V; Brodan V; Válek J
    Act Nerv Super (Praha); 1972; 14(2):113-4. PubMed ID: 5040151
    [No Abstract]   [Full Text] [Related]  

  • 16. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients.
    Greenspan K; Schildkraut JJ; Gordon EK; Levy B; Durell J
    Arch Gen Psychiatry; 1969 Dec; 21(6):710-6. PubMed ID: 4901154
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary monoamine metabolites in children with minimal brain dysfunction.
    Wender PH; Epstein RS; Kopin IJ; Gordon EK
    Am J Psychiatry; 1971 Apr; 127(10):1411-5. PubMed ID: 5549938
    [No Abstract]   [Full Text] [Related]  

  • 18. A psychopharmacological study of catecholamines in affective disorders.
    Messiha FS; Savage C; Turek I; Hanlon TE
    J Nerv Ment Dis; 1974 May; 158(5):338-47. PubMed ID: 4823934
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary excretion of catecholamines and their principal metabolites in arterial hypertension].
    Korenev NM; Rasin MS
    Vrach Delo; 1972 Feb; 2():78-81. PubMed ID: 5084752
    [No Abstract]   [Full Text] [Related]  

  • 20. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M; Karoum F; Miller T; Potter WZ
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.